• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA Further Clarifies Sampling Inspection Procedures for Medical Devices (Draft Amendment)

NMPA Further Clarifies Sampling Inspection Procedures for Medical Devices (Draft Amendment)

Sampling Inspection
Tuesday, 24 November 2020 / Published in Medical Device, News, NMPA Registration in China

NMPA Further Clarifies Sampling Inspection Procedures for Medical Devices (Draft Amendment)

On October 13, the NMPA (National Medical Products Administration) issued the draft document to improve the work efficiency of sampling inspection procedures and minimize processing times.

What’s new in the proposed regulation?

  • The inspection facilities’ application process and requirements
  • Workflow to ensure the newly designed checklist form has been completed before the inspection
  • The procedure to confirm the samples before the inspection will be removed

The NMPA has made announcements on March 10, 2020 (No.9-2020) and May 13, 2020 (No.46-2020), which served as a key basis to the development of the draft proposal. Read our previous articles about both announcements (No.9-2020 & No.46-2020).

NMPA Legal Agents will play a more important role when the document is finalized, due to their increased involvement in the sampling process and post-market surveillance requirements generally.

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Sampling Inspection

What you can read next

NMPA simplifies registration of certain dietary supplements
Periodic Risk Evaluation Reports for Medical Device Adverse Events – New Guidelines Issued
NMPA Fast-Track Approvals: New Overseas Applications Accepted and Domestic Approvals Passed

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Children cosmetics technical guidelines in China

    Children cosmetics technical guidelines in China – Newly issued by NIFDC

    Children cosmetics technical guidelines in Chin...
  • pH Determination Method

    China’s cosmetic safety technical specifications – 21 revision items issued

    China’s cosmetic safety technical specifi...
  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2003-2023 Cisema. All rights reserved.

TOP